Sansure Biotech (SHSE:688289) Shares Outstanding (Basic Average): 622 Mil (As of Mar. 2026)

Sansure Biotech SHSE:688289 +1.80% 67 Shares Outstanding (Basic Average) is 622 Mil as of Mar. 2026. GuruFocus rates SHSE:688289 with a GF Score™ of 67/100 and a GF Value™ of ¥20.52 (Possible Value Trap). The stock has 7 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Sansure Biotech's average basic shares outstanding for the quarter that ended in Mar. 2026 was 622 Mil.

Sansure Biotech (SHSE:688289) Shares Outstanding (Basic Average) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Be Aware

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.

Sansure Biotech Shares Outstanding (Basic Average) Related Terms

Sansure Biotech Shares Outstanding (Basic Average) Historical Data

* Premium members only.

The historical data trend for Sansure Biotech's Shares Outstanding (Basic Average) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sansure Biotech Shares Outstanding (Basic Average) Chart

Sansure Biotech Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Shares Outstanding (Basic Average)

Get a 7-Day Free Trial

588.63

585.14

586.65

586.38

585.11

Sansure Biotech Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Shares Outstanding (Basic Average)	Get a 7-Day Free Trial															573.35	588.94	577.00	601.16	621.74

67GF Score

Sansure Biotech Inc SHSE:688289

Shares Outstanding (Basic Average) is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Sansure Biotech Shares Outstanding (Basic Average) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that exact time point. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

Frequently Asked Questions Learn more about Shares Outstanding (Basic Average) →

What does a Shares Outstanding (Basic Average) of 622 Mil mean?

Sansure Biotech (SHSE:688289) has a Shares Outstanding (Basic Average) of 622 Mil as of Mar. 2026. The average shares outstanding over two periods not accounting for dilutive securities like convertible bonds. View historical data on Sansure Biotech and its competitors.

Is Sansure Biotech's Shares Outstanding (Basic Average) too high?

Sansure Biotech's current Shares Outstanding (Basic Average) is 622 Mil. Overall, Sansure Biotech has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does Sansure Biotech's Shares Outstanding (Basic Average) compare to ISRG and BDX?

Sansure Biotech's Shares Outstanding (Basic Average) of 622 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Shares Outstanding (Basic Average) for a Medical Devices & Instruments company?

A good Shares Outstanding (Basic Average) depends on the Medical Devices & Instruments industry context. However, Shares Outstanding (Basic Average) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Shares Outstanding (Basic Average) mean?

A high Shares Outstanding (Basic Average) can signal that a stock is expensive relative to its fundamentals. The average shares outstanding over two periods not accounting for dilutive securities like convertible bonds. View historical data on Sansure Biotech and its competitors. Sansure Biotech's current Shares Outstanding (Basic Average) is 622 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Sansure Biotech stock overvalued right now?

Based on GuruFocus' analysis, Sansure Biotech (SHSE:688289) is currently considered Possible Value Trap. The stock's GF Value™ is ¥20.52, compared to a current price of ¥14.12 — trading 31.2% below its estimated fair value. The current Shares Outstanding (Basic Average) is 622 Mil. Sansure Biotech's overall GF Score™ is 67/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Shares Outstanding (Basic Average) calculated?

Shares Outstanding (Basic Average) is calculated from a company's financial statements. For Sansure Biotech (SHSE:688289), the current Shares Outstanding (Basic Average) is 622 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sansure Biotech (SHSE:688289) Overvalued in 2026?

Based on GuruFocus' analysis, Sansure Biotech stock appears to be undervalued. The current stock price of ¥14.12 is trading 31.2% below its estimated GF Value™ of ¥20.52. GuruFocus considers Sansure Biotech to be Possible Value Trap.

Key valuation signals for SHSE:688289:

Shares Outstanding (Basic Average): 622 Mil
GF Value™: ¥20.52 vs. price of ¥14.12 (31.2% below fair value)
GF Score™: 67/100 with 7 warning signs

No single metric tells the full story. See the SHSE:688289 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.